Literature DB >> 28323495

Vision-related Quality of Life in Patients with Non-infectious Uveitis: A Cross-sectional Study.

Pedro Arriola-Villalobos1, Lydia Abásolo2,3, Julián García-Feijoo1,4, Benjamín Fernández-Gutiérrez2, Rosalía Méndez-Fernández1, Esperanza Pato2, David Díaz-Valle1, Luis Rodriguez-Rodriguez2,3.   

Abstract

PURPOSE: To analyze the influence of socio-demographic, comorbidity, and clinical-related variables in the vision-related quality of life (VR-QoL) of non-infectious uveitis patients.
METHODS: Cross-sectional study includes 156 consecutive non-infectious uveitis patients from a tertiary uveitis clinic from Madrid (Spain). The main outcome was the log-transformed composite score of the Visual Functioning Questionnaire 25. Bivariate and multivariate ordinary least-squares regression models were performed and results expressed using effect sizes with 95% confidence intervals (95% CI).
RESULTS: In the multivariate analysis, one unit increase in the logarithm of the minimum angle of resolution scale [i.e., worse best corrected visual acuity (BCVA)] was associated with a seven times worse VR-QoL (a 0.14-fold change [95% CI: 0.07-0.27]). Patients with ocular comorbidities had a 64% worse VR-QoL (a 0.61-fold change [95% CI: 0.49-0.77]).
CONCLUSIONS: Lower BCVA and the presence of ocular comorbidities had a significant, independent, and deleterious effect in the VR-QoL of non-infectious uveitis patients.

Entities:  

Keywords:  Cross-sectional study; ocular comorbidities; uveitis; vision-related quality of life; visual acuity

Mesh:

Year:  2017        PMID: 28323495     DOI: 10.1080/09273948.2017.1285034

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

1.  Time Trade-off Utility Values in Noninfectious Uveitis.

Authors:  Katherine M Niemeyer; John A Gonzales; Thuy Doan; Erica N Browne; Maya M Rao; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2019-06-13       Impact factor: 5.258

2.  Long-term prognosis for glaucoma in patients with Posner-Schlossman syndrome.

Authors:  Jin-Ho Kim; Ji-Young Lee; Jin A Choi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-23       Impact factor: 3.117

3.  Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer's perspective.

Authors:  Seenu M Hariprasad; George Joseph; Patrick Gagnon-Sanschagrin; Elizabeth Serra; Subrata Bhattacharyya; Jérôme Bédard; Annie Guérin; Thomas Arno Albini
Journal:  BMJ Open Ophthalmol       Date:  2021-11-10

4.  Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study.

Authors:  Ana Belen Rivas; Amanda Lopez-Picado; Valentina Calamia; Ester Carreño; Lidia Cocho; Miguel Cordero-Coma; Alex Fonollosa; Felix M Francisco Hernandez; Angel Garcia-Aparicio; Javier Garcia-Gonzalez; Jose Juan Mondejar; Leticia Lojo-Oliveira; Llucí Martínez-Costa; Santiago Munoz; Diana Peiteado; Jose Antonio Pinto; Beatriz Rodriguez-Lozano; Esperanza Pato; David Diaz-Valle; Elena Molina; Luis Alberto Tebar; Luis Rodriguez-Rodriguez
Journal:  BMJ Open       Date:  2022-03-22       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.